the Congo approved four experimental treatments that will be used in the outbreak of ebola this affects the northeast of the country, while the medical staff wants to limit its expansion in the midst of the threat of armed militias in the region.
The health personnel can use ZMapp, Remdesivir, Favipiravir and Regn3450 – 3471 – 3479, the Health Ministry said on Wednesday. The previous day, Remdesivir, from Gilead Sciences, was used on a patient in Beni, the ministry said.
Medical authorities began to use the treatment mAb114 on 11 August in 10 patients who are evolving well, he added.
the tenth Ebola outbreak in Congo it was declared on 1 August in Mangina, province of North Kivu.
According to the latest official data, there are 75 confirmed cases of lethal haemorrhagic fever and probably 27. Of the 59 recorded deaths, it was confirmed that 32 were caused by Ebola.
More than 1,600 people have been vaccinated since 8 August in Mabalako and Beni, North Kivu, and in Mandima, Ituri province, the ministry said.
Insecurity in the region, especially in what the World Health Organization calls "red zones" controlled by various armed groups, hinders efforts to care for the sick.
Also read: Ebola again: record breakout in DRC
North Kivu is a densely populated area with 1 million displaced people. The authorities say that the local population, in the vicinity of the very busy border with Uganda, is not familiar with Ebola, hence the importance of giving information.
the ebola It is transmitted through the body fluids of the infected, living or dead, and depending on the strain, up to 90% of cases can be fatal.